KSTP anchor and reporter Brett Hoffland begins chemotherapy Monday to treat his testicular cancer, according to an update he posted to his Facebook page.
Hoffland revealed in April that he had been diagnosed with testicular cancer and had a "successful surgery" that removed his left testicle.
But further testing showed his cancer is embryonal non-seminoma – one of the most rapidly growing and potentially aggressive testicular cancer tumor types, his CaringBridge page says. This means his cancer could recur or it could be spreading.
He was given three choices to treat the cancer: aggressive surveillance, more surgery or chemotherapy.
He and his wife decided he'd go in for retroperitoneal lymph node dissection surgery, with the surgery scheduled for June 10. But that didn't happen because his tumor marker blood levels crept up before surgery.
"A meeting with our urologist and oncologist at Mayo Clinic solidified what once was our 'worst-case scenario' would now become our reality," the CaringBridge page says. "Cancer was actively growing in Brett's body, meaning he was now classified at Stage 2. Chemotherapy was the only option to treat it."
So on Monday, Hoffland is starting nine weeks of chemotherapy, the page says. He and his wife will travel back and forth between Rochester and the Twin Cities for his treatment.
"This will not be an easy road to walk down, especially in the midst of a pandemic, but we are trying to focus on the things we are grateful for," the page adds.
The American Cancer Society (ACS) says that the average age for a testicular cancer diagnosis is 33, and it occurs in one in every 250 men.
Fortunately, the mortality rate is very low, with a man's lifetime risk of dying from testicular cancer being about 1 in 5,000.
Early symptoms of the cancer include a lump or swelling of the testicle, and aching in the lower belly, though the ACS notes that some men have no symptoms at all and the cancer is found during other procedures.